跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
艾可拓 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Pioglitazone Hydrochloride Tablets
Approved
化学药品
Pioglitazone Hydrochloride Tablets
TEVA TAKEDA YAKUHIN LTD.
🇨🇳 National Medical Products Administration
Approval Date
Aug 8, 2019
Approval ID
7MazXbJKLX9
Company
TEVA TAKEDA YAKUHIN LTD.
Type
化学药品
Approval Details
Approval Id
7MazXbJKLX9
Approval Number
H20140269
Generic Name
盐酸吡格列酮片
Generic Name En
Pioglitazone Hydrochloride Tablets
Trade Name
艾可拓
Drug Type
化学药品
Dosage Form
片剂
Strength
15mg(按吡格列酮计)
Reg Date
2019-08-08
Expired Date
2023-12-06
Company Name
TEVA TAKEDA YAKUHIN LTD.
Company Address
1-24-11, Taiko, Nakamura-ku, Nagoya-shi, Aichi, JAPAN
Production Company Name
takeda pharmaceutical company limited, hikari plant
Production Company Address
4720, Takeda, Mitsui, Hikari, Yamaguchi 743-8502, Japan
Company Detail Path
/organization/teva-takeda-yakuhin-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Aug 8, 2019
Approval ID
7MazXbJKLX9
Type
化学药品
Back to NMPA Approvals